Biomerica (BMRA) Cash & Equivalents Growth (5y) (2015 - 2026)
Biomerica (BMRA) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -24.01% |
| Nov 30, 2025 | -14.86% |
| Aug 31, 2025 | -15.21% |
| May 31, 2025 | -18.76% |
| Feb 28, 2025 | 5.04% |
| Nov 30, 2024 | 22.75% |
| Aug 31, 2024 | 28.41% |
| May 31, 2024 | 43.44% |
| Feb 29, 2024 | 42.10% |
| Nov 30, 2023 | 44.69% |
| Aug 31, 2023 | 68.75% |
| May 31, 2023 | 51.82% |
| Feb 28, 2023 | 41.15% |
| Nov 30, 2022 | 44.02% |
| Aug 31, 2022 | 41.24% |
| May 31, 2022 | 37.01% |
| Feb 28, 2022 | 45.85% |
| Nov 30, 2021 | 34.91% |
| Aug 31, 2021 | 22.42% |
| May 31, 2021 | 17.33% |